Phillip Fromm’s Post

What are biologic drugs and why are they important in the fight against cancer and other diseases? Find out how biologic medicines provide more treatment options for people who suffer from untreated or undertreated conditions, and discover Teva’s innovative work in this space: https://lnkd.in/dzE9CUu4

What are biologic drugs and why are they important in the fight against cancer and other diseases? Find out how biologic medicines provide more treatment options for people who suffer from untreated or undertreated conditions, and discover Teva’s innovative work in this space: https://lnkd.in/eX8ZMVWz

What are biologic drugs and why are they important in the fight against cancer and other diseases? Find out how biologic medicines provide more treatment options for people who suffer from untreated or undertreated conditions, and discover Teva’s innovative work in this space: https://lnkd.in/dfNDF4tE

What are biologic drugs and why are they important in the fight against cancer and other diseases? Find out how biologic medicines provide more treatment options for people who suffer from untreated or undertreated conditions, and discover Teva’s innovative work in this space: https://lnkd.in/gjxSQDD4

What are biologic drugs and why are they important in the fight against cancer and other diseases? Find out how biologic medicines provide more treatment options for people who suffer from untreated or undertreated conditions, and discover Teva’s innovative work in this space: https://lnkd.in/dgxKUWdH

As scientists and pharmaceutical industries continue to recognize the potential health benefits of 3-deoxyanthocyanidins, the challenge of extracting these compounds from Sorghum grains has created an unmet demand. Fortunately, Jobelyn supplement has emerged as a solution, harnessing the power of Sorghum bicolor leaf sheaths to provide a natural and effective source of 3-deoxyanthocyanidins. The Science Behind 3-Deoxyanthocyanidins: These powerful compounds have shown promise in combating chronic diseases, including cancer, due to their antioxidant, anti-inflammatory, and chemopreventive properties. National Cancer Institute Recognition: The National Cancer Institute (NCI) has listed Sorghum bicolor supplement as a potential anti-cancer agent in its dictionary of cancer drugs, validating the scientific community's interest in this natural compound.

I 'd like to explore an example of the successful use of biologic drugs using the treatment of rheumatoid arthritis (RA), an #autoimmune disease characterized by persistent joint inflammation. Biological drugs are complex molecules produced using living cells ⚗ One of the most widely studied biologic drugs for the RA therapy is #adalimumab (a recombinant human monoclonal #antibody obtained by expression in CHO cells). It works by inhibiting the activity of tumor necrosis factor (TNF) and other molecules involved in the inflammatory process. This targeted approach not only reduces inflammation, but also slows disease progression, improving patients' quality of life. Systematic review published in The Lancet highlighted that patients treated with TNF inhibitors, including adalimumab, had a 50-70% reduction in disease activity compared to those on placebo❗ This dramatic reduction in symptoms has allowed many patients to return to normal activities, which had previously been impossible due to the debilitating nature of the disease. As research continues and new #biologics are developed, their impact on patient care is expected to grow, offering relief and improved quality of life to even more individuals suffering from chronic, debilitating diseases.

Today is #RareDiseaseDay, dedicated to raising awareness and generating change for the 300 million people worldwide living with a rare disease, their families and caretakers. At ARMGO, we are committed to making a difference for rare disease patients by developing our proprietary Rycal® drugs. Rycals are novel small molecule therapeutics that repair leaky ryanodine receptor (RyR) channel proteins. These drugs have the potential to become a powerful new treatment option for patients suffering from Catecholaminergic Polymorphic Ventricular Tachycardia (#CPVT), a rare, genetic #arrhythmia and RYR1-related myopathy (RYR1-RM), a rare muscle disease. To find out more about Rare Disease Day, visit: https://lnkd.in/gk6hbAF. #RareDiseaseDay #CPVT #RYR1-RM #RYR-1Foundation

The benefits of CBD can sometimes be exaggerated by what's a hopeful use of hemp versus a practical use of the plant. While CBD does have anti-inflammatory properties, its uses in cancer to prevent disease progression have not yet been proven outside of animal models. Unfortunately, a recent Australian study offered little hope that could be replicated in humans after a clinical trial and did not demonstrate CBD's effectiveness in altering disease outcomes or extending life in advanced-stage cancer patients. This research emphasizes the need for more comprehensive studies to understand CBD's role in cancer treatment. Tap the link in the comments to read more about the study. #cbd #cbdoil #hemp #brandprotection #cannabis

📢 Promising Drug Blocks Epstein Barr Virus Diseases 🌟 Hornet Therapeutics, a spin-out from the University of Basel, has published first data on its preclinical IDO1 blocker HTX-201. They aim to start clinical tests within the next 12 to 18 months to target post-transplant lymphoproliferative disease. 🏥 This small molecule drug has the potential to block a target used by the Epstein Barr virus to cause diseases. 🦠 #BioprocessUpdates #HornetTherapeutics #EBV #diseaseblocker #HTX201 #clinicaltests #posttransplantlymphoproliferativedisease #smallmoleculedrug #EpsteinBarrvirus #preclinicaldata #UniversityofBasel #virusrelateddiseases #antiviraltherapy #medicalresearch #transplantmedicine #innovationinmedicine ▷ Read the full article here: 📎 https://lnkd.in/dSTEbP3u